Esophageal Cancer
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2006; 12(16): 2505-2509
Published online Apr 28, 2006. doi: 10.3748/wjg.v12.i16.2505
Table 1 Baseline characteristics of study population with or without COPD undergoing transthoracic esophagectomy
CharacteristicsCOPD(n = 86, %)Non-COPD(n = 272, %)P value
Age, yr61.3 ± 5.563.2 ± 7.10.522
Sex (male:female)63/23191/810.638
Smoking history79 (91.9)214 (78.7)< 0.01
Past medical history
Hypertension16 (18.6)48 (17.6)0.840
Cardiac disease13 (15.1)35 (12.9)0.594
Diabetes10 (11.6)33 (12.1)0.900
Cancer stage
I17 (19.8)56 (20.6)0.869
II48 (55.8)145 (53.3)0.685
III21 ( 24.4)71 (26.1)0.115
IV00-
Site of anastomosis
Neck32 (37.2)108 (39.7)0.679
Chest54 (62.8)164 (60.3)0.679
Duration of operation (min)162.75 ± 51.05185.15 ± 66.240.239
Blood loss (mL)365.50 ± 219.36434.00 ± 232.480.344
Low serum albumin (< 35g/L)25 (29.1)89 (32.7)0.526
Spirometry
FEV1 (L)1.6 ± 0.32.3 ± 0.5< 0.01
FEV1,% predicted51.5 ± 10.580.4 ± 13.1< 0.01
FEV1/FVC,%57.6 ± 8.973.3 ± 6.8< 0.01
DLCO,% predicted83.7 ± 13.485.0 ± 13.90.774
Table 2 Pulmonary complications occurring in patients with or without COPD undergoing transthoracic esophagectomy
Pulmonary complicationsCOPD(n = 86)Non-COPD(n = 272)P value
Pneumonia1519< 0.01
Atelectasis1315< 0.01
Pulmonary abscess450.227
Prolonged O2 supplement1011< 0.01
Prolonged mechanical ventilation810< 0.05
Acute respiratory distress syndrome54< 0.05
Table 3 Degree of COPD and outcomes in patients with or without POPC in COPD group
Severity of COPDPOPCs (n = 29)Non-POPCs (n = 57)P value
FEV1,%predicted
GradeI(> 80%)1035< 0.05
GradeIIA (50%-80%)1319
GradeIIB (30%-50%)63
GradeIII (< 30%)00
Table 4 Comparison of PaO2 changes in the first postoperative week in patients with or without POPCs in COPD group (mean±SD)
TimePOPCsNon-POPCsP
1 preoperative day82.17 ± 7.3782.75 ± 4.450.758
1 postoperative day68.38 ± 5.2476.00 ± 8.28< 0.01
2 postoperative day61.83 ± 7.0369.05 ± 7.78< 0.01
3 postoperative day61.75 ± 6.1467.20 ± 7.35< 0.05
4 postoperative day62.71 ± 4.9370.15 ± 9.34< 0.01
5 postoperative day61.13 ± 5.6272.75 ± 10.30< 0.001
6 postoperative day61.83 ± 6.4976.55 ± 9.62< 0.001
7 postoperative day61.63 ± 6.3180.45 ± 7.50< 0.001
Table 5 Comparison of PaCO2 changes in the first postoperative week in patients with or without POPCs in COPD group (mean ± SD)
TimePOPCsNon-POPCsP
`1 preoperative day42.85 ± 4.1042.37 ± 6.030.766
1 postoperative day44.42 ± 4.6141.24 ± 4.93< 0.05
2 postoperative day45.35 ± 4.9741.38 ± 5.19< 0.05
3 postoperative day46.02 ± 4.8842.45 ± 5.62< 0.05
4 postoperative day46.01 ± 5.5639.10 ± 3.59< 0.001
5 postoperative day44.63 ± 5.3140.62 ± 5.44< 0.05
6 postoperative day45.95 ± 6.5642.03 ± 5.60< 0.05
7 postoperative day45.18 ± 5.8040.49 ± 6.13< 0.05
Table 6 Comparison of SaO2 changes in the first postoperative week in patients with or without POPCs in COPD group (mean±SD)
TimePOPCsNon-POPCsP
1 preoperative day94.48 ± 1.9394.44 ± 1.510.940
1 postoperative day94.56 ± 1.1893.78 ± 1.800.095
2 postoperative day94.01 ± 1.9494.30 ± 1.390.572
3 postoperative day95.39 ± 1.1594.56 ± 1.750.077
4 postoperative day94.65 ± 1.2795.31 ± 1.150.079
5 postoperative day94.94 ± 1.3994.26 ± 1.810.176
6 postoperative day94.88 ± 1.6094.96 ± 1.740.868
7 postoperative day95.02 ± 1.1694.61 ± 1.900.399